Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06961916 · ClinicalTrials.gov registry record · NA

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2)

A NA study of Schizophrenia, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT06961916 is a NA study of Schizophrenia that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 120 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06961916, a NA study of Schizophrenia, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

Patients with schizophrenia spectrum disorder (SSD) will be exposed to active repetitive transcranial magnetic stimulation (rTMS) from H coil combined with cognitive training for improving white matter integrity.

Conditions Studied

Interventions

  • DEVICE Active rTMS
  • BEHAVIORAL Cognitive Training

Study Locations (1)

Texas

  • The University of Texas Health Science Center, Houston - Houston

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2025-06-03
Est. Completion 2029-05-01
Phase NA

What the Registry Record Tells You About NCT06961916

The ClinicalTrials.gov registry entry for NCT06961916 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (45% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Active rTMS is the first listed.

NCT06961916 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06961916 about?

NCT06961916 is a clinical study titled "Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2)". Patients with schizophrenia spectrum disorder (SSD) will be exposed to active repetitive transcranial magnetic stimulation (rTMS) from H coil combined with cognitive training for improving white matter integrity.

What is the current status of trial NCT06961916?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-06-03. Estimated completion is 2029-05-01.

What conditions does trial NCT06961916 study?

This clinical trial studies the following conditions: Schizophrenia.

What interventions are being tested in trial NCT06961916?

The interventions under investigation include: Active rTMS (DEVICE), Cognitive Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT06961916?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06961916 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.